About
MeNow is an AI-driven discovery company focused on developing novel natural bioactive compounds for FOOD, COSMETICS & HEALTH. The company integrates advanced probabilistic AI, systems biology, and molecular science to identify and validate new bioactives with strong efficacy, safety, and scalability profiles. Through this approach, MeNow has achieved a breakthrough in longevity-relevant biology, generating proprietary intellectual property around key pathways such as SIRT1 activation, heparanase modulation, and GLP-1–associated mechanisms, with applications across metabolic health, inflammation, tissue function, and healthspan support. Its work bridges fundamental biology and real-world applications, enabling the translation of advanced discoveries into impactful consumer and health solutions.